Besides age-related disease, metformin has a beneficial effect in the treatment of cancer by inhibiting metabolism, reducing protumorigenic signaling through NF-κB inhibition, and reducing stemness in cancer cells that escape oncogene-induced senescence (Deschenes-Simard et al., 2019). This evidence concerns the gene NFKB1 and cancer.